Safety and Effectiveness of Long-term Allopurinol–Thiopurine Maintenance Treatment in Inflammatory Bowel DiseaseFrank Hoentjen, Adriaan A. van Bodegraven, Margien L. Seinen et al.|Inflammatory Bowel Diseases|2012Cited by 102
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registryVince Biemans, Jasmijn A M Sleutjes, Annemarie C. de Vries et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 87
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort StudyLauranne Derikx, Frank Hoentjen, Marten A. Lantinga et al.|Journal of Crohn s and Colitis|2020Cited by 71
Rac1 as a Potential Pharmacodynamic Biomarker for Thiopurine Therapy in Inflammatory Bowel DiseaseMargien L. Seinen, Adriaan A. van Bodegraven|Therapeutic Drug Monitoring|2016Cited by 29